David McDonnell
Alkermes, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David McDonnell as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:28 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05303064 · Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderAlkermes, Inc. · recruiting · Schizophrenia, Bipolar I Disorder · study director
- Ph3NCT04987229 · Long-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsAlkermes, Inc. · enrolling by invitation · Bipolar I Disorder, Schizophrenia · study director
- Ph1NCT04987658 · Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I DisorderAlkermes, Inc. · completed · Bipolar I Disorder · study director
- Ph1NCT02922426 · An Insulin Sensitivity Study in Healthy SubjectsAlkermes, Inc. · completed · Healthy Volunteers · study director
- Ph1NCT02804568 · A Phase 1 Safety Study in Adults With SchizophreniaAlkermes, Inc. · completed · Schizophrenia · study director
- Ph3NCT02634346 · A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)Alkermes, Inc. · completed · Schizophrenia · study director
- Ph2NCT02161718 · A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use DisorderAlkermes, Inc. · completed · Schizophrenia, Alcohol Use Disorder · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:28 UTC. The ranking covers the 200 most relevant of 37 PubMed records, and a shared surname and initials can bring in a namesake. All 37 on PubMed
- Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein.Circulation · 2002284 citationsRCR 7.2
- Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia.Am J Psychiatry · 2010165 citationsRCR 6.4
- An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia.J Clin Psychiatry · 2008107 citationsRCR 4.0
- 101 citationsRCR 2.8
- Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression.Br J Psychiatry · 201289 citationsRCR 3.5
- Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study.Am J Psychiatry · 202089 citationsRCR 6.1
- D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophrenia.Neuropsychopharmacology · 200860 citationsRCR 2.3
- Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia: Outcomes From the Randomized, Phase 3 ENLIGHTEN-1 Study.J Clin Psychiatry · 202048 citationsRCR 3.0
- An internet-based smoking cessation program for Korean Americans: results from a randomized controlled trial.Nicotine Tob Res · 201137 citationsRCR 1.7
- 33 citationsRCR 2.7